CardioKinetix
Menlo Park, California, United States
About CardioKinetix
The Company, based in Menlo Park, has developed a novel transcatheter implant called the PARACHUTETM Ventricular Partitioning Device (PARACHUTETM). The PARACHUTETM intends to treat heart failure resulting from a heart attack or myocardial infarction in millions of patients worldwide by improving overall cardiac function.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $112.5M
- Funding stage: Late Stage Venture
- Last round: Series F (Nov 2016)
- Website: cardiokinetix.com
- Phone: 650-364-7016
Industries & Categories
Biotechnology, Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/cardiokinetix-2504545 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.